Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 18, 2026, 4:00 PM EDT
7.08
-0.04 (-0.56%)
Pre-market: Mar 19, 2026, 6:20 AM EDT
Climb Bio Employees
As of December 31, 2025, Climb Bio had 29 total employees, including 28 full-time and 1 part-time employees. The number of employees increased by 11 or 61.11% compared to the previous year.
Employees
29
Change (1Y)
11
Growth (1Y)
61.11%
Revenue / Employee
n/a
Profits / Employee
-$2,063,828
Market Cap
340.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 11 | 61.11% | 28 | 1 |
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 305 |
| AC Immune | 172 |
| Nautilus Biotechnology | 130 |
| Neurogene | 107 |
| Silence Therapeutics | 88 |
| Armata Pharmaceuticals | 60 |
| PepGen | 57 |
| NovaBridge Biosciences | 32 |
CLYM News
- 13 days ago - Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 weeks ago - Climb Bio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026 - GlobeNewsWire
- 4 months ago - Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy - GlobeNewsWire
- 5 months ago - Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 - GlobeNewsWire
- 6 months ago - Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer - GlobeNewsWire